March 2025 Highlights: Biotech Deals, Clinical Advances, and Emerging Therapies 11 months ago ByJohnIn Funding RoundsPartnershipsPharma Industry UpdatesResearch UpdatesTop Stories
Sun Pharma Acquires Checkpoint Therapeutics to Expand Oncology and Immunotherapy Portfolio 11 months ago ByJohnIn Funding RoundsPartnershipsPharma Industry UpdatesTop Stories
AstraZeneca’s Billion-Dollar Acquisition and Strategic Deals Highlight March Biopharma M&A Boom 11 months ago ByJohnIn Funding RoundsPartnershipsPharma Industry UpdatesTop StoriesVenture Capital
Eli Lilly’s EBGLYSS Shows Sustained Skin Clearance at Three Years in Moderate-to-Severe Atopic Dermatitis 11 months ago ByJohnIn Biopharma HighlightsClinical TrialsInnovationTop Stories
Breakthrough Collaborations in AI-Driven Drug Discovery Accelerate Biopharma Innovation 11 months ago ByJohnIn AI & DataInnovationPartnershipsPharma Industry Updates
Sustained Growth in Cell and Gene Therapy Manufacturing Sparks New Opportunities in North America 11 months ago ByJohnIn Biopharma ManufacturingFunding RoundsInnovationPharma Industry UpdatesTop Stories
Pharma Industry Updates: Europe’s Fast-Track Approvals Fuel Growth in Rare Disease Therapeutics 11 months ago ByJohnIn FDA ApprovalsFunding RoundsPharma Industry UpdatesResearch UpdatesVenture Capital
Industry Conferences Drive Biopharma Collaboration and Innovation Across Asia-Pacific 11 months ago ByJohnIn Industry ConferencesInnovationPartnershipsPharma Industry UpdatesTop Stories
Venture Capital Surge Fuels Australian Biotech Startups in Oncology and Rare Diseases 12 months ago ByJohnIn Funding RoundsPartnershipsResearch UpdatesStartupsTop StoriesVenture Capital
Breakthrough in Alzheimer’s Prevention: New Trial Shows Promise for First-in-Class Early Intervention Therapy 12 months ago ByJohnIn Clinical TrialsInnovationPartnershipsResearch UpdatesTop Stories
Continuous Glucose Monitoring Developer Secures Injection of Capital to Fuel Diagnostic Innovation 12 months ago ByJohnIn BreakthroughsInnovationPharma Industry Updates
Venture Capital Flows Back Into Biotech With Renewed Strength 12 months ago ByJohnIn Top StoriesVenture Capital
Afrigen and Tourmaline Secure Major Funding to Advance Critical Clinical Research and Therapeutics 12 months ago ByJohnIn Biopharma HighlightsResearch Updates
Eli Lilly’s $27 Billion Investment Highlights Surge in Biotech Funding and Strategic Partnerships 12 months ago ByJohnIn DealsInvestmentsPeople
Takeda Seals Major $770 Million Drug Design Partnership While Other Biotech Firms Secure Vital Financing 12 months ago ByJohnIn Funding RoundsInvestmentsPeopleVenture Capital
